Warning letter
Health Facilities Inc.: warning letter of Feb 18, 1999
FDA warning letter UCM067119 · Baltimore District Office
Key facts
| Reference number | UCM067119 |
|---|---|
| Company | Health Facilities Inc. |
| Subject | Medical Gases / CGMP |
| Issue date | Feb 18, 1999 |
| Posted date | Feb 18, 1999 |
| Issuing office | Baltimore District Office |
| Product type | Drugs |
| CFR sections cited | 21, 211 |
| Country | 3 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: